家族性肺纤维化的遗传图谱
该研究对569个家族性肺纤维化家系进行了全外显子组和/或候选基因测序,发现14.9-23.4%的遗传风险可由已知FPF相关基因的罕见变异解释,以端粒相关基因占主导。研究还识别了新的候选基因和通路,但未发现跨家系共享的新罕见变异基因,提示大多数FPF家系的遗传风险由涉及多种基因和通路的异质性变异介导。
要点
- 家族性肺纤维化中14.9-23.4%的遗传风险由已知FPF基因的罕见变异解释。
- 端粒相关基因是已知FPF相关基因中的主要贡献者。
- 新候选基因包括SYDE1、SERPINB8、GPR87和NETO1,但未发现跨家系共享的新基因。
核心结论
- 在迄今最全面的FPF遗传研究中,明确了已知FPF相关基因罕见变异的 prevalence,并识别了新的候选基因和通路。
- 未发现跨多个家系共享的新罕见变异基因,提示大多数FPF家系的遗传风险由涉及多种基因和通路的异质性变异介导。
研究设计与样本
- 对569个家族性肺纤维化家系中的 affected individuals 进行全外显子组测序和/或候选基因测序。
- 随后在大 家系中进行共分离分析、基因负荷分析、基于基因的风险评分、细胞类型富集分析和共表达网络构建。
主要发现
- 14.9-23.4%的遗传风险可由先前与FPF相关的基因中的罕见变异解释,主要是端粒相关基因。
- 在少数家系中识别了新的候选基因,包括SYDE1、SERPINB8、GPR87和NETO1,并开发了用于评估和优先排序含罕见变异基因的工具。
- FPF中含罕见变异的基因富集于多个通路,包括粘着斑和线粒体复合物I组装。
- 结合单细胞转录组学与优先候选基因,发现含罕见变异基因的表达富集于平滑肌细胞、II型肺泡上皮细胞和内皮细胞。
局限性
- 未发现跨多个家系共享的新罕见变异基因,提示大多数FPF家系的遗传风险由异质性变异介导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale and Objectives: Up to 20% of idiopathic interstitial lung disease is familial, referred to as familial pulmonary fibrosis (FPF). An integrated analysis of FPF genetic risk was performed by comprehensively evaluating for genetic rare variants (RVs) in a large cohort of FPF kindreds. Methods: Whole-exome sequencing and/or candidate gene sequencing from affected individuals in 569 FPF kindreds was performed, followed by cosegregation analysis in large kindreds, gene burden analysis, gene-based risk scoring, cell-type enrichment analysis, and coexpression network construction. Measurements and Main Results: It was found that 14.9-23.4% of genetic risk in kindreds could be explained by RVs in genes previously linked to FPF, predominantly telomere-related genes. New candidate genes were identified in a small number of families-including SYDE1, SERPINB8, GPR87, and NETO1-and tools were developed for evaluation and prioritization of RV-containing genes across kindreds. Several pathways were enriched for RV-containing genes in FPF, including focal adhesion and mitochondrial complex I assembly. By combining single-cell transcriptomics with prioritized candidate genes, expression of RV-containing genes was discovered to be enriched in smooth muscle cells, type II alveolar epithelial cells, and endothelial cells. Conclusions: In the most comprehensive FPF genetic study to date, the prevalence of RVs in known FPF-related genes was defined, and new candidate genes and pathways relevant to FPF were identified. However, new RV-containing genes shared across multiple kindreds were not identified, thereby suggesting that heterogeneous genetic variants involving a variety of genes and pathways mediate genetic risk in most FPF kindreds.
引用
- Liu Q, Zhou Y, Cogan JD, et al. The Genetic Landscape of Familial Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023. PMID: 36622818. doi:10.1164/rccm.202204-0781OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。